RE:Stockbuphoon Yes, that is an interesting thought that Boehringher should just pounce now but I would imagine that thomvest would not sell and they own the majority. It would drive price up a bit but they couldn't get control from thomvest. The deal on the table was real in 2018 and valuations in 2018 of $10 by a very well respected US Investment Bank are real as well.
Steve33 wrote:
The companies that know the clinical data on the 4050 pbi indications that almost made a supposed deal with Pierre could buy Liminal for next to nothing getting their cash and small molecule assets. That would be extremely cheap and probably the best steal ever. That is if the Alstom trial was legit.